AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12377628
Drug: Domestically manufactured
RxNorm normalized name: domestic cow dander extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domestically manufactured low-molecular-weight heparin
Trial: 12377628
Drug: Imported low-molecular-weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imported low-molecular-weight heparin
Trial: 1358620
Drug: Ebastine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ebastine (20 mg)
Trial: 7752640
Drug: Alcohol (0.35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol (0.35 g/kg)
Trial: 2271194
Drug: Droperidol (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droperidol (both doses)
Trial: 30985632
Drug: Single 900-mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single 900-mg oral dose of delafloxacin
Trial: 30985632
Drug: Single 250-mg
RxNorm normalized name: docusate
DrugBank: Docusate (DB11089)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single 250-mg intramuscular ceftriaxone
Trial: 16399173
Drug: Levofloxacin 750
RxNorm normalized name: levofloxacin 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levofloxacin 750 mg for 5 days
Trial: 16399173
Drug: Levofloxacin 500
RxNorm normalized name: levofloxacin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levofloxacin 500 mg for 10 days
Trial: 9006374
Drug: Fluorouracil/epinephrine gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluorouracil/epinephrine gel
Trial: 9006374
Drug: Fluorouracil gel
RxNorm normalized name: Fluorouracil
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluorouracil gel alone
Trial: 8433075
Drug: Dietary fructose
RxNorm normalized name: Fructose
DrugBank: Fructose (DB04173)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dietary fructose (20% of carbohydrate calories, 45‐65 g day‐1 for 4 weeks)
Trial: 2825941
Drug: Isoproterenol, terbutaline,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoproterenol, terbutaline, and epinephrine (beta-agonists)
Trial: 2825941
Drug: Beta 1‐
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta 1‐ and beta 2‐receptor stimulation
Trial: 29846653
Drug: DHA (2.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA (2.7 g/d)
Trial: 22429693
Drug: Health Workshops
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Health Workshops (8 weekly sessions)
Trial: 8653019
Drug: Solipid 20%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solipid 20% S&E (lipid emulsions based on soy oil with egg lecithin or soy lecithin) administered at 1 g/kg body weight on day 1 and 2 g/kg/day on days 2-5
Trial: 1455403
Drug: Dermatan sulphate
RxNorm normalized name: Dermatan sulphate
DrugBank: Dermatan sulfate (DB15880)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dermatan sulphate (DS) 2-4 mg/kg
Trial: 1455403
Drug: Dermatan sulphate
RxNorm normalized name: Dermatan sulphate
DrugBank: Dermatan sulfate (DB15880)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dermatan sulphate (DS) 5-6 mg/kg
Trial: 1455403
Drug: Dermatan sulphate
RxNorm normalized name: Dermatan sulphate
DrugBank: Dermatan sulfate (DB15880)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dermatan sulphate (DS) 3 mg/kg
Trial: 1455403
Drug: Dermatan sulphate
RxNorm normalized name: Dermatan sulphate
DrugBank: Dermatan sulfate (DB15880)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dermatan sulphate (DS) 6 mg/kg
Trial: 1455403
Drug: Dermatan sulphate
RxNorm normalized name: Dermatan sulphate
DrugBank: Dermatan sulfate (DB15880)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dermatan sulphate (DS) 3 mg/kg plus infusion of 0.6 mg kg‐1 h‐1
Trial: 1455403
Drug: Dermatan sulphate
RxNorm normalized name: Dermatan sulphate
DrugBank: Dermatan sulfate (DB15880)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dermatan sulphate (DS) 5 mg/kg plus infusion of 1 mg kg‐1 h‐1
Trial: 1455403
Drug: Standard unfractionated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard unfractionated heparin (UFH)
Trial: 27856475
Drug: Medical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical therapy alone (Control)
Trial: 30212961
Drug: LED applications
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LED applications (intra oral with 660 nm, 12J and extraoral with 850 nm, 108J)
Trial: 25430452
Drug: Continuous adductor
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous adductor canal block with 0.2% ropivacaine at 5 ml/h
Trial: 25430452
Drug: Continuous femoral
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous femoral nerve block with 0.2% ropivacaine at 5 ml/h
Trial: 22540635
Drug: CC +
RxNorm normalized name: CC
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CC + NAC (100 mg/d clomiphene citrate + 1.2 g/d N-acetylcysteine)
Trial: 22540635
Drug: CC +
RxNorm normalized name: CC
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CC + Placebo (100 mg/d clomiphene citrate + placebo)
Trial: 20630595
Drug: Anti-VEGF agent
RxNorm normalized name: Anti-VEGF monoclonal antibody
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Anti-VEGF agent (ranibizumab)
Trial: 17599560
Drug: Oral corticosteroid
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral corticosteroid treatment
Trial: 8297690
Drug: Benazepril (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benazepril (10 mg twice daily)
Trial: 8297690
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of benazepril and nifedipine
Trial: 2920133
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg dihydrocodeine
Trial: 4405419
Drug: Low-dose marijuana
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose marijuana (4.8 mg Delta(9)-THC followed by 2.4 mg one hour later)
Trial: 4405419
Drug: High-dose marijuana
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose marijuana (9.1 mg Delta(9)-THC followed by 4.5 mg one hour later)
Trial: 31200349
Drug: Supervised aerobic
RxNorm normalized name: camphor
DrugBank: Camphor (DB01744)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Supervised aerobic and resistance exercise of moderate to vigorous intensity 3 times per week until the end of treatment, then twice per week for 10 weeks, followed by once per week for 10 weeks
Trial: 25531162
Drug: GS-4997 (ASK1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GS-4997 (ASK1 inhibitor), once daily, oral administration
Trial: 24101040
Drug: Dose-dense temozolomide
RxNorm normalized name: Temozolomide
DrugBank: Temozolomide (DB00853)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dose-dense temozolomide (arm 2) for 6 to 12 cycles
Trial: 24101040
Drug: Dose-dense temozolomide
RxNorm normalized name: Temozolomide
DrugBank: Temozolomide (DB00853)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dose-dense temozolomide (arm 2)
Trial: 12064924
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups (calcitriol and enzyme therapy)
Trial: 10458121
Drug: 0.2 percent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 percent topical glyceryl trinitrate ointment
Trial: 328139
Drug: Radiation alone
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Radiation alone or in combination with chemotherapy
Trial: 328139
Drug: Chemotherapy followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chemotherapy followed by immunotherapy
Trial: 28924366
Drug: Dexmedetomidine in
RxNorm normalized name: dexmedetomidine Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine in combination with fentanyl-based IV-PCA (dIV-PCA group)
Trial: 21863672
Drug: AS03(A)‐adjuvanted H5N1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AS03(A)‐adjuvanted H5N1 influenza vaccine
Trial: 21863672
Drug: Non‐adjuvanted H5N1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non‐adjuvanted H5N1 vaccine formulations
Trial: 9692166
Drug: albendazole (alb)
RxNorm normalized name: Albendazole
DrugBank: Albendazole (DB00518)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: albendazole (alb) 600 mg + ivermectin (iver) 400 micrograms/kg
Trial: 9692166
Drug: albendazole (alb)
RxNorm normalized name: Albendazole
DrugBank: Albendazole (DB00518)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: albendazole (alb) 600 mg
Trial: 9692166
Drug: albendazole (alb)
RxNorm normalized name: Albendazole
DrugBank: Albendazole (DB00518)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: albendazole (alb) 600 mg + diethylcarbamazine (DEC) 6 mg/kg
Trial: 9692166
Drug: diethylcarbamazine (DEC)
RxNorm normalized name: diethylcarbamazine
DrugBank: Diethylcarbamazine (DB00711)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: diethylcarbamazine (DEC) 6 mg/kg + ivermectin (iver) 400 micrograms/kg
Trial: 7599511
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (45 mg daily for 60 days)
Trial: 31721978
Drug: P2Y12 inhibitor
RxNorm normalized name: Fibrinolysis inhibitor
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: P2Y12 inhibitor copayment reduction intervention (vouchers waiving copayments for 1 year)
Trial: 23938046
Drug: Cognitive Behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioural Therapy
Trial: 17171602
Drug: Family-Focused Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Family-Focused Treatment
Trial: 15103479
Drug: Topical negative
RxNorm normalized name: GLYCERIN NEGATIVE CONTROL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical negative pressure, maggot therapy, electromagnetic therapy, therapeutic ultrasound, growth factors
Trial: 1288660
Drug: Low-dose levodopa,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose levodopa, bromocriptine, or a combination of both drugs
Trial: 29373734
Drug: Testosterone treatment
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone treatment for 36 months
Trial: 29373734
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment for 36 months
Trial: 25080051
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide (40 ppm)
Trial: 25080051
Drug: Sham inhaled
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham inhaled nitric oxide administration
Trial: 20673983
Drug: Inhaled corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled corticosteroids (ICS) - Budesonide
Trial: 8873389
Drug: 23‐valent pneumococcal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 23‐valent pneumococcal polysaccharide vaccine
Trial: 15641062
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment (methotrexate + etanercept)
Trial: 15641062
Drug: Monotherapy (methotrexate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy (methotrexate or etanercept)
Trial: 11465011
Drug: Individual and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individual and group psychotherapy, cognitive-behavioral therapy, 12-step programmes
Trial: 11465011
Drug: Serotonin (5-hydroxytryptamine;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serotonin (5-hydroxytryptamine; 5-HT) re-uptake inhibitors
Trial: 9459044
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg enteric-coated tablet
Trial: 9459044
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg capsule
Trial: 3306891
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g ASA and 1 g sucralfate four times daily
Trial: 3306891
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g ASA four times daily and placebo tablets
Trial: 3306891
Drug: No drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No drugs administered
Trial: 26162632
Drug: Rituximab 1000mg
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Rituximab 1000mg twice at 2 weeks interval
Trial: 16868064
Drug: Intensive insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive insulin therapy (strict blood glucose control to normoglycemia with insulin)
Trial: 16004778
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no intensive insulin therapy)
Trial: 16868064
Drug: Hydrocortisone administration
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Hydrocortisone administration (replacement dose)
Trial: 9255748
Drug: Oral micronized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral micronized 17 beta‐estradiol/oral sequential dydrogesterone
Trial: 9255748
Drug: Transdermal 17
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal 17 beta‐estradiol/oral sequential dydrogesterone
Trial: 9255748
Drug: Oral tibolone
RxNorm normalized name: TIBOLONE
DrugBank: Tibolone (DB09070)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral tibolone
Trial: 26604653
Drug: BS capsules
RxNorm normalized name: BS-001
DrugBank: BS-001 (DB17415)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BS capsules containing glucoraphanin (GR) for 2 months
Trial: 23164309
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy plus daily enemas for 2 weeks
Trial: 21823381
Drug: Bupivacaine infiltration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine infiltration of the skin and subcutaneous tissue
Trial: 18655817
Drug: Daily ingestion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily ingestion of a strong-gelling sodium alginate formulation for 7 days
Trial: 8786777
Drug: Gabexate (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabexate (1 g by intravenous infusion starting 30 to 90 minutes before endoscopy and continuing for 12 hours afterward)
Trial: 8786777
Drug: Placebo (mannitol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (mannitol and sodium chloride administered in the same fashion)
Trial: 10655924
Drug: Hartmann's solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hartmann's solution
Trial: 24970272
Drug: 6% Hydroxyethyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6% Hydroxyethyl starch (130/0.4) + 500 ml of Ringer's lactate (HES group)
Trial: 24970272
Drug: Ringer's lactate
RxNorm normalized name: Ringer's lactate/gel dressing 2.2" TOPICAL KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ringer's lactate (1000 ml) (RL group)
Trial: 15531687
Drug: Total calcium
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total calcium intake (>1767 mg/d)
Trial: 15531687
Drug: Calcium supplement
RxNorm normalized name: Calcium supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium supplement use (>1200 mg/d)
Trial: 11374604
Drug: 0 microg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 microg/kg intrathecal morphine (saline injection)
Trial: 11374604
Drug: 2 microg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 microg/kg intrathecal morphine
Trial: 11374604
Drug: 5 microg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 microg/kg intrathecal morphine
Trial: 12660683
Drug: Candesartan cilexetil
RxNorm normalized name: Candesartan Cilexetil
DrugBank: Candesartan cilexetil (DB00796)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Candesartan cilexetil 2 mg
Trial: 8488994
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg amiphenazole
Trial: 3547126
Drug: Cyclosporine (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporine (6 mg per kilogram of body weight per day)
Trial: 30741813
Drug: IV acetaminophen
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV acetaminophen (1,000 mg)
Trial: 24309584
Drug: Daily language
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily language rehabilitation for 2 weeks (starting 2.2 days poststroke)
Trial: 24309584
Drug: Daily language
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily language rehabilitation
Trial: 22951346
Drug: Electrically Heated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electrically Heated Cigarette Smoking System (EHCSS) and EHCSS‐K3 cigarette (3mg tar, 0.2mg nicotine, and 0.6 mg CO)
Trial: 19567902
Drug: High-fidelity assertive
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-fidelity assertive community treatment (ACT)
Trial: 7522004
Drug: Both laser
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both laser treatments
Trial: 10362451
Drug: Creatine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine supplementation (CR, 5 g creatine monohydrate + 3 g dextrose)
Trial: 10362451
Drug: Placebo supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo supplementation (PLA, 7 g dextrose)
Trial: 29064315
Drug: Trichuris suis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trichuris suis (TSO) treatment
Trial: 29064315
Drug: Baseline versus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline versus treatment (BVT) control
Trial: 9734653
Drug: Quinine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinine (30 mg/kg/d)
Trial: 7983237
Drug: Single doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single doses of NM441 (20, 50, 100, 200, and 400 mg)
Trial: 7983237
Drug: Multiple doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple doses of NM441 (300 mg twice daily for 6.5 days)
Trial: 7983237
Drug: Single doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single doses of NM441 (100, 200, and 400 mg)
Trial: 7983237
Drug: Single doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single doses of NM441 (400 mg)
Trial: 7983237
Drug: Single doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single doses of NM441
Trial: 7983237
Drug: Multiple doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple doses of NM441
Trial: 2648779
Drug: Patients with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients with all three risk characteristics (no history of previous angina or myocardial infarction, ST segment elevation or signs of Q wave development, peak MB-creatine kinase value ≥ 150 IU/L)
Trial: 773016
Drug: Oral estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral estrogen Quinestrol
Trial: 773016
Drug: Injected drug
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injected drug
Trial: 31004346
Drug: ACT-709478 (1-400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACT-709478 (1-400 mg)
Trial: 31004346
Drug: ACT-709478 (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACT-709478 (60 mg)
Trial: 29135373
Drug: Silymarin 1,050
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silymarin 1,050 mg/day
Trial: 2707520
Drug: Silymarin 420
RxNorm normalized name: silymarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silymarin 420 mg/day
Trial: 14571350
Drug: Venlafaxine ER
RxNorm normalized name: Venlafaxine ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine ER (75 mg, could be increased to 150 mg)
Trial: 14571350
Drug: Amitriptyline ER
RxNorm normalized name: amitriptyline Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline ER (75 mg, could be increased to 150 mg)
Trial: 1816937
Drug: Grommets inserted
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Grommets inserted as a primary treatment
Trial: 24275098
Drug: Dolutegravir 50
RxNorm normalized name: dolutegravir 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dolutegravir 50 mg as a tablet
Trial: 24275098
Drug: Dolutegravir 50
RxNorm normalized name: dolutegravir 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dolutegravir 50 mg in 10 g of granule administered directly to mouth
Trial: 24275098
Drug: Dolutegravir 50
RxNorm normalized name: dolutegravir 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dolutegravir 50 mg in 10 g of granule mixed with purified water
Trial: 24275098
Drug: Dolutegravir 50
RxNorm normalized name: dolutegravir 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dolutegravir 50 mg in 10 g of granule mixed with water containing high cation concentrations
Trial: 24275098
Drug: Dolutegravir 50
RxNorm normalized name: dolutegravir 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dolutegravir 50 mg in 10 g of granule mixed with milk-based infant formula
Trial: 10989902
Drug: Laparoscopic skills
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laparoscopic skills training using simulated tasks on a video-trainer for 30 minutes daily for 10 days
Trial: 1463596
Drug: 70 mg/Kg/die
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 70 mg/Kg/die of reduced glutathione (GSH)